It is critical to understand the events regulating CD47 gene expression at the transcriptional level as this has the potential to lead to alternative cancer gene therapies targeting the upstream group of transcription factors, epigenetic modifiers and molecular pathways responsible for CD47 upregulation, thus allowing for the recruitment of the host innate immune system to specifically recognize, target and destroy the cancer tumorigenic cells. This evidence concerns the gene CD47 and cancer.